Personalised medicines account for 60% of the over 5,600 active products
currently in the global pharmaceutical industry’s R&D pipeline....Read more at: http://www.pharmatimes.com/Article/14-04-11/UK_at_risk_over_personalised_medicines_report_warns.aspx#ixzz2yeCWB9RH
No comments:
Post a Comment